КраткосрочноСреднесрочноДолгосрочноСигналы

Aclaris Therapeutics Inc [ACRS]

Биржа: NASDAQ
Сектор: Healthcare
Отрасль: Biotechnology
Последнее обновление 22 Jun 2026 @ 10:08 (Exchange is open)
Последняя: $0 0.00%
-0.41 (↓)
GaG Algo Score™
v1.0
Короткий
-0.41 (↓)
Средний
0.74 (↓)
Длинный
1.25 (↓)

Статистика

Объем сегодня 0
Средний объем 0
Капитализация 542.68M
EPS $-0.150 (Q1 | 2026-05-07)
Следующая дата отчетности ($-0.160) 2026-08-06
ATR14 $0.246 (5.47%)
Возможный дневной размах $4.38 - $4.62 (5.62%)

Уровни поддержки и сопротивления

Линия

Pivot-данные

Статистика pivot
Метрика Среднее Медиана Ст. откл.
Рост % 44.76% 47.84% 22.70%
Падение % -18.84% -15.87% 9.70%
Длительность 20.9d 18d 14.5d
Всего найдено pivot 13
Фазы роста/падения 12 (6 Рост / 6 Падение)
Последний pivot Top @ $4.71 на 2026-06-04
Изменение с последнего pivot $-0.21 (-4.46%)
Прогноз следующего pivot Последняя: $0.00
Ожидаемый следующий тип Bottom
Прогноз цены (средн.) $3.82
Прогноз цены (медиана) $3.96
Прогноз диапазона цены (~68%) $3.37 - $4.28
Изменение к средней цели $3.82 (N/A)
Прогноз даты (средн.) 2026-06-24
Прогноз диапазона дат (~68%) 2026-06-10 - 2026-07-09
Основа Based on 6 historical losses (Avg: -18.84%, Median: -15.87%, StdDev of Abs: 9.70%) and duration (Avg: 20.9 days, StdDev: 14.5 days)
Примечание Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Moderate gain for Aclaris Therapeutics Incon Thursday .

Aclaris Therapeutics Inc (ACRS) stock price made a notable advance on Thursday after the stock rose $0.0800 (1.81%) from the previous session on extraordinarily high volume. The stock moved in line with the rising NASDAQ that gained 1.91%. With 4.32M shares traded, volume yesterday reached $19.45M. This was 3.14M shares more than the prior day. Compared to the 10-day average of 1.16M shares, volume was more than the average.

Aclaris Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (3.3%), medium- (3.3%), and long-term (3.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Aclaris Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $4.53. approximately $0.0300 (0.67%) away. Pushing up towards resistance. Breaking above this level could signal further upside where next resistance level will be found at $4.55. On a fall back there will be support at $4.43 The dis das resistance s14.43 -

Aclaris Therapeutics Inc Evaluation

  • Короткий оценка: -0.41
  • Средний оценка: 0.74
  • Длинный оценка: 1.25